News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘MultipleMyeloma’ clear

  • Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.

Tags: Grants, MultipleMyeloma

  • The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study by researchers at Dana-Farber Cancer.

Tags: BasicResearch, MultipleMyeloma

  • A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising treatment for patients with advanced multiple myeloma when the targeted drug bortezomib stops working alone.

Tags: MultipleMyeloma

  • Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma. A study of the genomes from 38 cancer samples has yielded insights into the events that lead to this form of blood cancer and could influence the direction of multiple myeloma research.

Tags: MultipleMyeloma, Genetics

  • A study led by Dana-Farber investigators found that a phase 1 trial of an immune checkpoint blocker found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation.

Tags: MultipleMyeloma, Leukemia, Immunotherapy

  • Dana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.

Tags: BasicResearch, MultipleMyeloma

  • A new three-drug combination has shown to be "highly effective" in the treatment of newly diagnosed multiple myeloma patients, say researchers from Dana-Farber Cancer Institute.

Tags: MultipleMyeloma

  • The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought.

Tags: BasicResearch, MultipleMyeloma, Genetics

  • Dana-Farber researchers report that multiple myeloma is driven to spread by a subset of the myeloma cells within a patient’s body, and that attacking those specific subsets with targeted drugs may be better targets for therapy.

Tags: BasicResearch, MultipleMyeloma

  • Dana-Farber researchers successfully disrupted the function of the gene MYC  by tampering with the gene's "on" switch and growth signals in multiple myeloma cells, offering promising strategy for treating myeloma and other cancers driven by the MYC gene.

Tags: BasicResearch, MultipleMyeloma

Showing 1-10 of 15 items